X4 Pharmaceuticals
XFOR
XFOR
51 hedge funds and large institutions have $5.33M invested in X4 Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-42
Holders Change %
-45.16%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
16
Reduced
17
Closed
52
Calls
$738K
Puts
$40K
Net Calls
+$698K
Net Calls Change
+$527K
Top Buyers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$252K |
| 2 |
Jane Street
New York
|
$185K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$153K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
$152K |
| 5 |
Millennium Management
New York
|
$148K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$0 |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
$0 |
| 3 |
BlackRock
New York
|
$341K |
| 4 |
Northern Trust
Chicago,
Illinois
|
$0 |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
$0 |